DNA mismatch repair enzyme immunohistochemistry in colorectal cancer: A comparison of biopsy and resection material

Pathology

Volumn 42, Issue 5, 2010, Pages 414-420

  Kumarasinghe, Anuttara Panchali ^a   De Boer, Bastiaan ^c   Bateman, Adrian C ^b   Kumarasinghe, Marian Priyanthi ^c  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^c PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Colorectal cancer; Immunohistochemistry; Microsatellite instability; Mismatch repair proteins

Indexed keywords

DNA BINDING PROTEIN; MICROSATELLITE DNA; MSH3 PROTEIN, HUMAN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE;

ADENOCARCINOMA; BIOPSY; COLON; COLORECTAL TUMOR; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; ENZYMOLOGY; GASTROINTESTINAL ENDOSCOPY; GENETICS; METABOLISM; PATHOLOGY; PROCEDURES; REOPERATION; REPRODUCIBILITY; SURGERY;

ADENOCARCINOMA; BIOPSY; COLON; COLORECTAL NEOPLASMS; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; ENDOSCOPY, GASTROINTESTINAL; IMMUNOENZYME TECHNIQUES; MICROSATELLITE REPEATS; REOPERATION; REPRODUCIBILITY OF RESULTS;

EID: 77954798529     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.3109/00313025.2010.493862     Document Type: Article

References (38)

1. Odze RD, Goldblum JR. Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas. 2nd ed. Philadelphia: Saunders, 2008; 598-605.
2. Brice P, editor. Biomarkers in Familial Colorectal Cancer Screening: Workshop Report and Recommendations. Cambridge: Public Health Genetics Unit, 2006.
3. Shia J. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: Part I. The utility of immunohistochemistry. J Mol Diagn 2008; 10: 293-300.
4. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for Cancer Detection and Familial Predisposition: Development of International Criteria for the Determination of Microsatellite Instability in Colorectal Cancer. Cancer Res 1998; 58: 5248-5257
5. Blanes A, Diaz-Cano SJ. Complementary analysis of microsatellite tumor profile and mismatch repair defects in colorectal carcinomas. World J Gastroenterol 2006; 12: 5932-5940
6. Chaves P CC, Lage P, Claro I, Cravo M, Leitão CN, Soares J. Immunohistochemical detection of mismatch repair gene proteins as a useful tool for the identification of colorectal carcinoma with the mutator phenotype. J Pathol 2000; 191: 355-360
7. Caldes T, Godino J, Sanchez A, et al. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer. Oncol Rep 2004; 12: 621-629
8. Ewald J, Rodrigue CM, Mourra N, et al. Immunohistochemical staining for mismatch repair proteins, and its relevance in the diagnosis of hereditary non-polyposis colorectal cancer. Br J Surg 2007; 94: 1020-1027
9. de Jong AE, van Puijenbroek M, Hendriks Y, et al. Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer. Clin Cancer Res 2004; 10: 972-980
10. Rigau V, Sebbagh N, Olschwang S, et al. Microsatellite instability in colorectal carcinoma. The comparison of immunohistochemistry and molecular biology suggests a role for hMSH6 immunostaining. Arch Pathol Lab Med 2003; 127: 694-700.
11. Pigatto F, Bateman A, Bunyan D, et al. Economic and Practical Factors in Diagnosing HNPCC Using Clinical Criteria, Immunohistochemistry and Microsatellite Instability Analysis. Hered Cancer Clin Pract 2004; 2: 175-184
12. Goldberg Y, Porat R, Sagi M, et al. A new oncogenetic service of counseling and diagnosing for hereditary non-polyposis colorectal cancer (HNPCC). (Hebrew.) Harefuah 2007; 146: 510-4, 76, 75.
13. Lindor NM, Burgart LJ, Leontovich O, et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002; 20: 1043-1048
14. Shia J, Klimstra DS, Nafa K, et al. Value of immunohistochemical detection of dna mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms. Am J Surg Pathol 2005; 29: 96-104.
15. Cunningham JM, Kim CY, Christensen ER, et al. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet 2001; 69: 780-790
16. Muller A, Giuffre G, Edmonston TB, et al. Challenges and pitfalls in HNPCC screening by microsatellite analysis and immunohistochemistry. J Mol Diagn 2004; 6: 308-315
17. Watson N, Grieu F, Morris M, et al. Heterogeneous staining for mismatch repair proteins during population-based prescreening for hereditary nonpolyposis colorectal cancer. J Mol Diagn 2007; 9: 472-478
18. Edmonston TB, Cuesta KH, Burkholder S, et al. Colorectal carcinomas with high microsatellite instability: Defining a distinct immunologic and molecular entity with respect to prognostic markers. Hum Pathol 2000; 31: 1506-1514
19. Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatelliteinstability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003; 349: 247-257
20. University of Birmingham. FOxTROT: A Multi-Centre Randomised Controlled Trial Comparing Colorectal Cancer Recurrence With Neoadjuvant Chemotherapy Versus Post-Operative Chemotherapy. Birmingham: University of Birmingham, 2009.
21. Samimi G, Fink D, Varki NM, et al. Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy. Clin Cancer Res 2000; 6: 1415-1421
22. Di Nicolantonio F, Mercer S, Knight L, et al. Cancer cell adaptation to chemotherapy. BMC Cancer 2005; 5: 78.
23. Royal College of Pathologists of Australasia (RCPA). Position Statement: Consent for Performing MSI and IHC Pre-screening for HNPCC. Sydney: RCPA Genetics Advisory Committee and Anatomical Pathology Advisory Committee, 2008.
24. Arends MIM, Happerfield L, Frayling I, Miller K. Interpretation of immunohistochemical analysis of mismatch repair (mmr) protein expression in tissue sections for investigation of suspected Lynch/ hereditary non-polyposis colorectal cancer (HNPCC) syndrome. UK NEQAS ICC & ISH Recommendations June 2008; Issue 1. Available at: http://www.cmgs.org/BPGs/pdfs%20current%20bpgs/ hnpcc%20recommendations%20B.pdf (accessed May 2010).
25. Altman DG. Practical Statistics for Medical Research. London: Chapman and Hall, 1991.
26. Campbell MJ, Machin D. Medical Statistics. A Commonsense Approach. 3rd ed. Chichester: John Wiley & Sons, 1999.
27. Boardman LA, Lanier AP, French AJ, et al. Frequency of defective DNA mismatch repair in colorectal cancer among the Alaska Native people. Cancer Epidemiol Biomarkers Prev 2007; 16: 2344-2350
28. Hameed F, Goldberg PA, Hall P, Algar U, van Wijk R, Ramesar R. Immunohistochemistry detects mismatch repair gene defects in colorectal cancer. Colorectal Dis 2006; 8: 411-417
29. Kohonen-Corish MR, Daniel JJ, Chan C, et al. Low microsatellite instability is associated with poor prognosis in stage C colon cancer. J Clin Oncol 2005; 23: 2318-2324
30. Samowitz WS, Curtin K, Ma K-N, et al. Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev 2001; 10: 917-923
31. Barnetson RA, Tenesa A, Farrington SM, et al. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med 2006; 354: 2751-2763
32. Valle L, Perea J, Carbonell P, et al. Clinicopathologic and pedigree differences in amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status. J Clin Oncol 2007; 25: 781-786
33. Jover R, Zapater P, Castells A, et al. Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer. Gut 2006; 55: 848-855
34. Alazzouzi H, Domingo E, Gonzalez S, et al. Low levels of microsatellite instability characterize MLH1 and MSH2 HNPCC carriers before tumor diagnosis. Hum Mol Genet 2005; 14: 235-239
35. Halvarsson B, Lindblom A, Johansson L, Lagerstedt K, Nilbert M. Loss of mismatch repair protein immunostaining in colorectal adenomas from patients with hereditary nonpolyposis colorectal cancer. Mod Pathol 2005; 18: 1095-1101
36. World Health Organization (WHO). Cancer: Colorectal Cancer. Geneva: WHO, February 2009. Available at: http://www.who.int/ cancer/en/ (accessed February 2009).
37. Gebert J, Sun M, Ridder R, et al. Molecular profiling of sporadic colorectal tumors by microsatellite analysis. Int J Oncol 2000; 16: 169-179
38. Jover R, Paya A, Alenda C, et al. Defective mismatch-repair colorectal cancer: clinicopathologic characteristics and usefulness of immunohistochemical analysis for diagnosis. Am J Clin Pathol 2004; 122: 389-394